Statement from FDA Commissioner on advancing new digital health policies to encourage innovation, bring efficiency and modernisation to regulation

FDA

7 December 2017 - Today we’re announcing three new, significant policy documents to advance the FDA’s approach to the development and proper oversight of innovative digital health tools. 

We know that consumers and health care providers are increasingly embracing digital health technologies to inform everyday decisions. From fitness trackers to mobile applications tracking insulin administration, these digital tools can provide consumers with a wealth of valuable health information. 

Further, clinical evidence demonstrates that consumers who are better informed about health make better and more efficient decisions, take steps to improve their lifestyles and their health choices, and often experience better outcomes.

Read FDA Statement


Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Innovation , Digital health